Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease

被引:0
|
作者
Hwan-Ching Tai
Bo Y Wang
Alberto Serrano-Pozo
Matthew P Frosch
Tara L Spires-Jones
Bradley T Hyman
机构
[1] National Taiwan University,Department of Chemistry
[2] University of Iowa Hospitals & Clinics,Department of Neurology
[3] Harvard Medical School,C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital
[4] University of Edinburgh,Centre for Cognitive and Neural Systems and the Euan MacDonald Centre for Motor Neurone Disease
[5] Harvard Medical School,MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital
关键词
Point Spread Function; Synaptic Terminal; Tauopathy; Postsynaptic Terminal; Stereological Counting;
D O I
暂无
中图分类号
学科分类号
摘要
The accumulation of neurofibrillary tangles in Alzheimer’s disease (AD) propagates with characteristic spatiotemporal patterns which follow brain network connections, implying trans-synaptic transmission of tauopathy. Since misfolded tau has been shown to transmit across synapses in AD animal models, we hypothesized that synapses in AD patients may contain misfolded tau. By immunofluorescence imaging of bipartite synapses from AD subjects, we detected tau protein in 38.4% of presynaptic and 50.9% of postsynaptic terminals. The pre/post distribution for hyperphosphorylated tau was 26.9%/30.7%, and for misfolded tau 18.3%/19.3%. In the temporal cortex, microscopic aggregates of tau, containing ultra-stable oligomers, were estimated to accumulate within trillions of synapses, outnumbering macroscopic tau aggregates such as tangles by 10000 fold. Non-demented elderly also showed considerable synaptic tau hyperphosphorylation and some misfolding, implicating the synapse as one of the first subcellular compartments affected by tauopathy. Misfolding of tau protein appeared to occur in situ inside synaptic terminals, without mislocalizing or mistrafficking. Misfolded tau at synapses may represent early signs of neuronal degeneration, mediators of synaptotoxicity, and anatomical substrates for transmitting tauopathy, but its actual role in these processes remain to be elucidated.
引用
收藏
相关论文
共 50 条
  • [1] Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease
    Tai, Hwan-Ching
    Wang, Bo Y.
    Serrano-Pozo, Alberto
    Frosch, Matthew P.
    Spires-Jones, Tara L.
    Hyman, Bradley T.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [2] Astrocytic tau deposition is frequent in Alzheimer disease
    Nolan, Amber
    De Paula, Elisa
    Resende, Franca
    Petersen, Cathrine
    Ehrenberg, Alexander
    Spina, Salvatore
    Miller, Bruce
    Seeley, William
    Grinberg, Lea
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (06): : 504 - 504
  • [3] Tau oligomers and aggregation in Alzheimer's disease
    Meraz-Rios, Marco A.
    Lira-De Leon, Karla I.
    Campos-Pena, Victoria
    De Anda-Hernandez, Martha A.
    Mena-Lopez, Raul
    JOURNAL OF NEUROCHEMISTRY, 2010, 112 (06) : 1353 - 1367
  • [4] Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer's Disease
    Serrano, G.
    Beach, T.
    Walker, J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 576 - 576
  • [5] Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer's Disease
    Serrano, Geidy E.
    Walker, Jessica
    Nelson, Courtney
    Glass, Michael
    Arce, Richard
    Intorcia, Anthony
    Cline, Madison P.
    Nabaty, Natalie
    Acuna, Amanda
    Steed, Ashton Huppert
    Sue, Lucia I.
    Belden, Christine
    Choudhury, Parichita
    Reiman, Eric
    Atri, Alireza
    Beach, Thomas G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [6] Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer's Disease
    Salvadores, Natalia
    Shahnawaz, Mohammad
    Scarpini, Elio
    Tagliavini, Fabrizio
    Soto, Claudio
    CELL REPORTS, 2014, 7 (01): : 261 - 268
  • [7] Tau oligomers as a therapeutic target for Alzheimer's disease
    Rakez, K.
    Gerson, J. E.
    Castillo-Carranza, D. L.
    Guerrero-Munoz, M.
    Sengupta, U.
    Barrett, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E7 - E7
  • [8] Tau oligomers in cerebrospinal fluid in Alzheimer's disease
    Sengupta, Urmi
    Portelius, Erik
    Hansson, Oskar
    Farmer, Kathleen
    Castillo-Carranza, Diana
    Woltjer, Randall
    Zetterberg, Henrik
    Galasko, Douglas
    Blennow, Kaj
    Kayed, Rakez
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (04): : 226 - 235
  • [9] Astrocytic Tau Deposition Is Frequent in Typical and Atypical Alzheimer Disease Presentations
    Nolan, Amber
    Franca Resende, Elisa De Paula
    Petersen, Cathrine
    Neylan, Kyra
    Spina, Salvatore
    Huang, Eric
    Seeley, William
    Miller, Zachary
    Grinberg, Lea T.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (12): : 1112 - 1123
  • [10] Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease
    Guerrero-Munoz, Marcos J.
    Gerson, Julia
    Castillo-Carranza, Diana L.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9 : 1 - 10